|
TCMBANKIN024541 |
Cistanoside E |
AC1NSTNG; (2R,3R,4R,5R,6R)-6-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[2-(4-hydroxy-3-methoxyphenyl)propoxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxane-2,3,4,5-tetrol; cistanoside e |
C21H32O12 |
476.47 |
CC1C(C(C(C(O1)OC2C(C(OC(C2O)OCCC3=CC(=C(C=C3)O)OC)CO)O)O)O)O |
|
TCMBANKIN036525 |
echinatine |
743IO8EFVG; AI3-51768; [(7S,8S)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate; AKOS030532774; Echinatine; UNII-743IO8EFVG; AK557898; [(7S,7AR)-7-HYDROXY-5,6,7,7A-TETRAHYDRO-3H-PYRROLIZIN-1-YL]METHYL (2S)-2-HYDROXY-2-[(1S)-1-HYDROXYETHYL]-3-METHYLBUTANOATE; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (1S-(1-alpha,7(2R,3S),7a-alpha))-; 480-83-1; LS-46251; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-t; NSC 89937; ZINC5481951; (2S,3S)-((1S,7AR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl 2,3-dihydroxy-2-isopropylbutanoate |
C15H25NO5 |
299.36 g/mol |
CC(C)C(C(C)O)(C(=O)OCC1=CCN2C1C(CC2)O)O |